Reuters logo
BRIEF-Sinclair IS Pharma H1 revenue rises 6.6 pct
March 25, 2014 / 7:11 AM / 3 years ago

BRIEF-Sinclair IS Pharma H1 revenue rises 6.6 pct

March 25 (Reuters) - Sinclair IS Pharma PLC : * Revenues growth 6.6% to £24.5 million (H1 13: £23.0 million) for the six months ended 31 December 2013 * Adjusted EBITDA* increased to £1.1 million (H1 13: £1.0 million) * Loss before tax reduced to £2.5 million (H1 13: loss of £5.8 million) * CEO says H1 results were marginally behind our expectations but these differences are now reversing * CEO says expect the full year results to be in line with our forecasts and with market expectations. * For more news, please click here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below